Drs Zeng join eBioMedicine to discuss their study of a novel molecular glue, called bufalin. Read the full article: <a href='https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(22)00535-7/fulltext'>Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy</a>Continue this conversation on social! Follow us today at... <a href='https://twitter.com/thelancet'>https://twitter.com/thelancet</a> <a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a> <a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a> <a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a> <a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a>

Peter Robinson and Justin Reese on Long COVID subtypes

Editors at eBioMedicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from climate change and health to microplastics in human tissues, the microbiome-gut-brain axis and binge drinking to computational pathology in 2030, and more.